YU32301A - Novi kristalni oblik omeprazola - Google Patents

Novi kristalni oblik omeprazola

Info

Publication number
YU32301A
YU32301A YU32301A YU32301A YU32301A YU 32301 A YU32301 A YU 32301A YU 32301 A YU32301 A YU 32301A YU 32301 A YU32301 A YU 32301A YU 32301 A YU32301 A YU 32301A
Authority
YU
Yugoslavia
Prior art keywords
methoxy
crystalline form
omeprazole
sulfinyl
benzimidazole
Prior art date
Application number
YU32301A
Other languages
English (en)
Inventor
Karin Lovqvist
David Noreland
Gunnel Sunden
Ingvar Ymen
Original Assignee
Astrazeneca Ab.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab. filed Critical Astrazeneca Ab.
Priority to YUP-323/01A priority Critical patent/RS49871B/sr
Publication of YU32301A publication Critical patent/YU32301A/sh
Publication of RS49871B publication Critical patent/RS49871B/sr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Ovaj pronalazak se odnosi na novi kristalni oblik 5-metoksi-2-[[4-metoksi-3,5-dimetil-2-piridil)metil]sulfinil-1H-benzimidazol, poznat po generičkom imenu omeprazol. Dalje, ovaj pronalazak se odnosi na upotrebu novog kristalnog oblika 5-metoksi-2-[[4-metoksi-,3,5-dimetil-2-piridil)metil]sulfinil-1H-benzimidazol za lečenje gastrolnterstinalnih poremećaja, farmaceutske kompozicije koje ga sadrže isto kao i postupak za dobijanje novog kristalnog oblika 5-metoksi-2-[[(4-metoksi-3,5-dimetil-2-piridil)metil]sulfinil-1H-benzimidazola.[The present invention relates to a novel crystalline form of 5-methoxy-2-[ [(4-methoxy-3,5-dimethyl- 2-pyridinyl)methyl] sulfinyl]1H- benzimidazole, know under the generic name omeprazole. Further, the present invention also relates to the use of the novel crystalline form of 5-methoxy-2-[ [4-methoxy-3,5-dimethyl- 2-pyridinyl)methyl] sulfinyl]-1H- benzimidazole for the treatment of gastrointestinal disorders, pharmaceutical compositions containing it as well as processes for the preparation of the novel crystalline form of 5- methoxy-2-[ [(4-methoxy-3,5-dimethyl- 2-pyridinyl)methyl] sulfinyl]1H-benzimidazole.
YUP-323/01A 1999-11-10 1999-11-10 Novi kristalni oblik omeprazola RS49871B (sr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
YUP-323/01A RS49871B (sr) 1999-11-10 1999-11-10 Novi kristalni oblik omeprazola

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YUP-323/01A RS49871B (sr) 1999-11-10 1999-11-10 Novi kristalni oblik omeprazola

Publications (2)

Publication Number Publication Date
YU32301A true YU32301A (sh) 2005-07-19
RS49871B RS49871B (sr) 2008-08-07

Family

ID=47739681

Country Status (1)

Country Link
RS (1) RS49871B (sh)

Also Published As

Publication number Publication date
RS49871B (sr) 2008-08-07

Similar Documents

Publication Publication Date Title
WO1999008500A3 (en) New crystalline form of omeprazole
MY127871A (en) Omeprazole sodium salt
MY119095A (en) Potassium salt of (s)-omeprazole
YU60999A (sh) Novi oblik s-omeprazola
HUP0303928A2 (hu) Omeprazol kristályos formája, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmények
YU32301A (sh) Novi kristalni oblik omeprazola
MXPA05009183A (es) Polimorfos de s-omeprazol.
MY118724A (en) New crystalline form of omeprazole